NASDAQ:ABAX - Nasdaq - US0025671050
83
-0.09 (-0.11%)
The current stock price of ABAX is 83 null. In the past month the price decreased by -0.06%. In the past year, price increased by 78.23%.
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Their mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. The Company provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.
ABAXIS INC
3240 WHIPPLE ROAD
UNION CITY CA 94587
CEO: Clinton H. Severson
Phone: 510-675-6500
The current stock price of ABAX is 83 null. The price decreased by -0.11% in the last trading session.
The exchange symbol of ABAXIS INC is ABAX and it is listed on the Nasdaq exchange.
ABAX stock is listed on the Nasdaq exchange.
ABAXIS INC (ABAX) has a market capitalization of 1.90B null. This makes ABAX a Small Cap stock.
ABAXIS INC (ABAX) has a support level at 82.99 and a resistance level at 83.11. Check the full technical report for a detailed analysis of ABAX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ABAXIS INC (ABAX) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.72. Check the full fundamental report for a detailed analysis of ABAX dividend history, reliability and sustainability.
The PE ratio for ABAXIS INC (ABAX) is 64.34. This is based on the reported non-GAAP earnings per share of 1.29 and the current share price of 83 null. Check the full fundamental report for a full analysis of the valuation metrics for ABAX.
ChartMill assigns a technical rating of 7 / 10 to ABAX. When comparing the yearly performance of all stocks, ABAX is one of the better performing stocks in the market, outperforming 93.81% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ABAX. ABAX has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months ABAX reported a non-GAAP Earnings per Share(EPS) of 1.29. The EPS increased by 1.57% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.11% | ||
ROA | 7.97% | ||
ROE | 9.35% | ||
Debt/Equity | 0 |